ACTOVEGIN® provides antihypoxic effect, stimulates tissue metabolism and regeneration, and improves trophism. It is used to treat impairments of brain blood circulation, such as syndrome of cerebral insufficiency, ischemic strokes, traumatic brain injury, and their complications; ulcers and burns of different genesis; hypoxia and ischemia of different tissues. Actovegin enhances physical performance and stamina. It works by improving glucose transportation and utilization, thus increasing oxygen consumption; by increasing the concentration of DNA, hemoglobin and hydroxyproline.
- Treat Metabolic and Cerebrovascular Disorders in the Brain.
- Eliminate Peripheral (Arterial and Venous) Vascular Disorders.
- Cure Ulcers of Various Origin.
- Treat Thermal and Chemical Burns.
- Reduce Hypoxia and Ischemia.
GUARANTEE & EXPIRY DATE
100% Original from the Japanese Takeda Pharmaceutical.
All packs are air tight sealed and expire up to 06.2023.
Further read https://en.wikipedia.org/wiki/Actovegin
Actovegin is a hemodialysate obtained from calf blood by ultrafiltration. It contains more than 200 biological substances. Actovegin is used to treat disorders of peripheral and cerebral blood circulation, burns, impaired wound, radiation-induced damage and diabetic polyneuropathy. It increases glucose uptake and improves oxygen uptake, thus normalizing metabolic balance and energy supply. Actovegin increases concentration of ATP, ADP, phosphocreatine, and has a large amount of amino acids (glutamate, aspartate) and GABA.
PACKAGING & DOSAGE
Actovegin comes in the form of tablets or solution for injection.
Active substance: deproteinized hemoderivative of calf blood - 200mg.
Excipients: magnesium stearate, povidone K90, talc, cellulose.
Coating composition: acacia gum - 6.8 mg, mountain glycol wax - 0.1 mg, hypromellose phthalate - 29.45 mg, diethyl phthalate - 11.8 mg, dye quinoline yellow aluminum varnish - 2.0 mg, macrogol 6000 - 2.95 mg, povidone K30 - 1.54 mg, sucrose - 52.3 mg, talc - 42.2 mg, titanium dioxide - 0.86 mg.
For oral administration.
Dosage: 1-2 tablets before meal 3 times/day. Course duration: 4-6 weeks. Can be repeated after 1.5-3 months break.
Actovegin® concentrate (in terms of dry deproteinized hemoderivative of calf blood) - 200 mg.
Excipients: water for injection - 5 ml.
Metabolic and vascular disorders of the brain: at the beginning of treatment 10 ml intravenously daily for two weeks, then 5-10 ml intravenously 3-4 times a week for at least 2 weeks.
Ischemic stroke: 20-50 ml in 200-300 ml of the main solution intravenously drip daily for 1 week, then 10-20 ml intravenously drip - 2 weeks.
Peripheral (arterial and venous) vascular disorders and their consequences: 20-30 ml of the drug in 200 ml of the main solution intraarterially or intravenously daily; the duration of treatment is about 4 weeks.
Wound healing: 10 ml intravenously or 5 ml intramuscularly daily or 3-4 times a week, depending on the healing process (in addition to local treatment with Actovegin in topical dosage forms).
Prevention and treatment of radiation injuries of the skin and mucous membranes during radiation therapy: the average dose is 5 ml intravenously daily in intervals of radiation exposure.
Radiation cystitis: daily 10 ml transurethrally in combination with antibiotic therapy.
The MHRA and FDA has not evaluated or endorsed this product. Please consult your physician prior to using this or any other nutritional supplements or medications.
Store in dry place. Do not exceed storage temperature of 25 degrees Celcius. Keep away from direct sunlight. Keep locked and away from children.
Ask us any questions about Actovegin.